DARMSTADT, GERMANY: Merck KGaA has unveiled a new technology for advanced live cell imaging, the CellASIC ONIX2 Microfluidic System. This system converts laboratory microscopes into powerful tools for live cell imaging to more effectively perform in-depth analysis of cellular mechanisms and behaviour in a live environment.
The next-generation CellASIC ONIX2 system permits exact control and manipulation of cell culture environments and provides constant, stable imaging conditions while preserving the health of cells.
The all-in-one system comprises a controller that keep up environmental conditions, with application-specific microfluidic plates and intuitive software.
With Merck’s new system, scientists can examine cellular responses to environmental changes such as media, stimulants, temperature and gas and track individual cells over time. By using microfluidic technology and a small cell culture chamber, these changes can be done faster and more consistently compared with traditional cell cultures.
The system’s cell culture platform can be used by drug discovery, basic and applied microbiological and mammalian cell researchers conducting semi-automated, repeatable long-term experiments while continuously collecting quantitative image-based data.
Additionally, this system provides a new level of reliability to researchers studying long-term growth, movement, signalling and cellular interactions and responses to environmental stimuli, including hypoxia and cancer cell behaviour. The system’s high-resolution capabilities are ideal for producing time-lapse cell culture videos or developing cell-based assays and optimising parameters for short- or long-term cultures.
“Live cell imaging is an essential instrument for researchers, allowing them to deepen their understanding of biological function, accelerating life-saving or life-extending therapies,” said Jason Apter, head of research solutions strategic marketing & innovation, life science.
“With the new CellASIC ONIX2 system, Merck is bringing this powerful tool to researchers in a reliable and easy-to-use system that helps them address their most pressing scientific questions,” added Apter.
“Microfluidic technology is changing the way we perform live cell analysis. The CellASIC ONIX microfluidic system is amazingly easy to use yet highly adaptable, which greatly reduces the barrier to adopting this emerging technology,” said Dr Jintao Liu, a researcher at the Suel Lab, University of California San Diego.
Read More: Merck unveils new microfluidic system for advanced live cell imaging
No comments:
Post a Comment